ArticleJournal for immunotherapy of cancer2023

T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy.

Bettzy Stephen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.